Skip to main content
SpringerLink
Log in

Alopecias

  • Chapter
Dermatological Manifestations of Kidney Disease

Abstract

Very little is written about the impact of chronic kidney disease on a patient’s hair. Perhaps this is because such patients often have many other manifestations of their disease that are considered far more serious. This chapter reviews the various factors that may cause alopecia associated with end-stage renal disease. While most instances of alopecia in end-stage renal disease are associated with telogen effluvium, this chapter examines common patterns and clinical courses. Categories reviewed include nutritional deficiencies, specifically iron and zinc deficiency, infectious associations including the human immunodeficiency virus syndrome and hepatitis, autoimmune disease, specifically systemic lupus erythematosus, and infiltrative causes such as amyloidosis. Also, a large portion of the chapter reviews drug induced causes of hair loss. A spectrum of drugs are discussed including those used in end-stage renal disease, those used in dialysis and drugs used after renal transplant.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nissenson AR, Strobos J. Iron deficiency in patients with renal failure. Kidney Int Suppl. 1999;69:S18–21.

    Article  CAS  PubMed  Google Scholar 

  2. Hard S. Non-anemic iron deficiency as an etiologic factor in diffuse loss of hair of the scalp in women. Acta Derm Venereol. 1963;43:562–9.

    Google Scholar 

  3. Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol. 2003;121(5):985–8.

    Article  CAS  PubMed  Google Scholar 

  4. Deloche C, Bastien P, Chadoutaud S, Galan P, Bertrais S, Hercberg S, et al. Low iron stores: a risk factor for excessive hair loss in non-menopausal women. Eur J Dermatol. 2007;17(6):507–12.

    CAS  PubMed  Google Scholar 

  5. Olsen EA, Reed KB, Cacchio PB, Caudill L. Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. J Am Acad Dermatol. 2010;63(6):991–9.

    Article  CAS  PubMed  Google Scholar 

  6. Sinclair R. There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol. 2002;147(5):982–4.

    Article  CAS  PubMed  Google Scholar 

  7. Dallman PR. Biochemical basis for the manifestations of iron deficiency. Annu Rev Nutr. 1986;6:13–40.

    Article  CAS  PubMed  Google Scholar 

  8. Hung KY, Wu DJ, Wu KD, Chen WY, Tsai TJ. Serum ferritin level required for adequate response to recombinant human erythropoietin in haemodialysis patients with hepatitis C virus infection. Nephrol Dial Transplant. 1998;13(10):2709–10.

    Article  CAS  PubMed  Google Scholar 

  9. Roozbeh J, Sharifian M, Sagheb MM, Shabani S, Hamidian Jahromi A, Afshariani R, et al. Comment on: does zinc supplementation affect inflammatory markers in hemodialysis patients? Ren Fail. 2011;33(4):466–7.

    Article  PubMed  Google Scholar 

  10. Haase H, Rink L. Zinc signals and immune function. Biofactors. 2013;40(1):27–40.

    Article  PubMed  Google Scholar 

  11. Daniells S, Hardy G. Hair loss in long-term or home parenteral nutrition: are micronutrient deficiencies to blame? Curr Opin Clin Nutr Metab Care. 2010;13(6):690–7.

    Article  CAS  PubMed  Google Scholar 

  12. Whitwam W, Lewis M, Rabb H. Alopecia in three women of Southeast Asian descent with chronic renal failure: possible association with erythropoietin use. Am J Kidney Dis. 2001;37(1):E9.

    CAS  PubMed  Google Scholar 

  13. Reddy V, Turney JH. Epoietin-alpha-associated total alopecia. Nephrol Dial Transplant. 2001;16(7):1525.

    Article  CAS  PubMed  Google Scholar 

  14. NKF K/DOQI Guidelines. [Internet] 2002. http://www.kidney.org/professionals/kdoqi/guidelines_bp/guide_11.htm.

  15. Smit AJ, Hoorntje SJ, Donker AJ. Zinc deficiency during captopril treatment. Nephron. 1983;34(3):196–7.

    Article  CAS  PubMed  Google Scholar 

  16. Motel PJ. Captopril and alopecia: a case report and review of known cutaneous reactions in captopril use. J Am Acad Dermatol. 1990;23(1):124–5.

    Article  CAS  PubMed  Google Scholar 

  17. Ahmad S. Enalapril and reversible alopecia. Arch Intern Med. 1991;151(2):404.

    Article  CAS  PubMed  Google Scholar 

  18. Leaker B, Whitworth JA. Alopecia associated with captopril treatment. Aust N Z J Med. 1984;14(6):866.

    Article  CAS  PubMed  Google Scholar 

  19. Graeber CW, Lapkin RA. Metoprolol and alopecia. Cutis. 1981;28(6):633–4.

    CAS  PubMed  Google Scholar 

  20. Hilder RJ. Propranolol and alopecia. Cutis. 1979;24(1):63–4.

    CAS  PubMed  Google Scholar 

  21. England JR, England JD. Alopecia and propranolol therapy. Aust Fam Physician. 1982;11(3):225–6.

    CAS  PubMed  Google Scholar 

  22. Shelley ED, Shelley WB. Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol. Cutis. 1985;35(2):148–9.

    CAS  PubMed  Google Scholar 

  23. Ochoa PG, Arribas MT, Mena JM, PĂˆrez MG. Cutaneous adverse reaction to furosemide treatment: new clinical findings. Can Vet J. 2006;47(6):576–8.

    PubMed Central  PubMed  Google Scholar 

  24. Sinclair R, Patel M, Dawson TL, Yazdabadi A, Yip L, Perez A, et al. Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness. Br J Dermatol. 2011;165 Suppl 3:12–8.

    Article  CAS  PubMed  Google Scholar 

  25. Sica DA. Calcium-channel blocker related peripheral edema: can it be resolved? J Clin Hypertens. 2003;5(4):291–5.

    Article  Google Scholar 

  26. Litt JZ. Litt’s pocketbook of drug erruptions and interactions. 3rd ed. New York: The Parthenon Publishing Group; 2004.

    Google Scholar 

  27. Olsen EA, Delong E, Weiner MS. Reply to A falling out following minoxidil: Telogen effluvium. J Am Acad Dermatol. 1987;16(1):145–6.

    Google Scholar 

  28. Segal AS. Alopecia associated with atorvastatin. Am J Med. 2002;113(2):171.

    Article  PubMed  Google Scholar 

  29. Ali A, Martin JM. Hair growth in patients alopecia areata totalis after treatment with simvastatin and ezetimibe. J Drugs Dermatol. 2010;9(1):62–4.

    PubMed  Google Scholar 

  30. Robins DN. Case reports: alopecia universalis: hair growth following initiation of simvastatin and ezetimibe therapy. J Drugs Dermatol. 2007;6(9):946–7.

    PubMed  Google Scholar 

  31. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011;377(9784):2181–92.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Barnes C, Deidun D, Hynes K, Monagle P. Alopecia and dalteparin: a previously unreported association. Blood. 2000;96(4):1618–9.

    CAS  PubMed  Google Scholar 

  33. Apsner R, Hˆrl WH, Sunder-Plassmann G. Dalteparin-induced alopecia in hemodialysis patients: reversal by regional citrate anticoagulation. Blood. 2001;97(9):2914–5.

    Article  CAS  PubMed  Google Scholar 

  34. Wang YY, Po HL. Enoxaparin-induced alopecia in patients with cerebral venous thrombosis. J Clin Pharm Ther. 2006;31(5):513–7.

    Article  PubMed  Google Scholar 

  35. Sarris E, Tsele E, Bagiatoudi G, Salpigidis K, Stavrianaki D, Kaklamanis L, et al. Diffuse alopecia in a hemodialysis patient caused by a low-molecular-weight heparin, tinzaparin. Am J Kidney Dis. 2003;41(5):E15.

    Article  PubMed  Google Scholar 

  36. Thomson AW, Bonham CA, Zeevi A. Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. Ther Drug Monit. 1995;17(6):584–91.

    Article  CAS  PubMed  Google Scholar 

  37. Price VH, Willey A, Chen BK. Topical tacrolimus in alopecia areata. J Am Acad Dermatol. 2005;52(1):138–9.

    Article  PubMed  Google Scholar 

  38. Tricot L, LebbĂˆ C, Pillebout E, Martinez F, Legendre C, Thervet E. Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients. Transplantation. 2005;80(11):1546–9.

    Article  CAS  PubMed  Google Scholar 

  39. Wise RP, Kiminyo KP, Salive ME. Hair loss after routine immunizations. JAMA. 1997;278(14):1176–8.

    Article  CAS  PubMed  Google Scholar 

  40. Geier DA, Geier MR. A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity. 2005;38(4):295–301.

    Article  CAS  PubMed  Google Scholar 

  41. Palekar NA, Harrison SA. Extrahepatic manifestations of hepatitis C. South Med J. 2005;98(10):1019–23.

    Article  PubMed  Google Scholar 

  42. Paoletti V, Mammarella A, Basili S, Paradiso M, Di Franco M, De Matteis A, et al. Prevalence and clinical features of skin diseases in chronic HCV infection. A prospective study in 96 patients. Panminerva Med. 2002;44(4):349–52.

    CAS  PubMed  Google Scholar 

  43. Jadali Z, Mansouri P, Jadali F. There is no relationship between hepatitis C virus and alopecia areata. Eur J Dermatol. 2006;16(1):94–5.

    CAS  PubMed  Google Scholar 

  44. Jackson JM, Callen JP. Scarring alopecia and sclerodermatous changes of the scalp in a patient with hepatitis C infection. J Am Acad Dermatol. 1998;39(5 Pt 2):824–6.

    Article  CAS  PubMed  Google Scholar 

  45. Kartal ED, Alpat SN, Ozgunes I, Usluer G. Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Eur J Gastroenterol Hepatol. 2007;19(9):817–20.

    Article  PubMed  Google Scholar 

  46. Demirturk N, Aykin N, Demirdal T, Cevik F. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin. Eur J Dermatol. 2006;16(5):579–80.

    PubMed  Google Scholar 

  47. Smith KJ, Skelton HG, DeRusso D, Sperling L, Yeager J, Wagner KF, et al. Clinical and histopathologic features of hair loss in patients with HIV-1 infection. J Am Acad Dermatol. 1996;34(1):63–8.

    Article  CAS  PubMed  Google Scholar 

  48. Mirmirani P, Hessol NA, Maurer TA, Berger TG, Greenblatt RM, Price VH. Hair changes in women from the Women’s Interagency HIV Study. Arch Dermatol. 2003;139(1):105–6.

    PubMed  Google Scholar 

  49. Green SL, Nelson DL. Straightening of the hair is not pathognomonic for HIV infection. Clin Infect Dis. 2002;35(10):1276–7.

    Article  PubMed  Google Scholar 

  50. Ostlere LS, Langtry JA, Staughton RC, Samrasinghe PL. Alopecia universalis in a patient seropositive for the human immunodeficiency virus. J Am Acad Dermatol. 1992;27(4):630–1.

    Article  CAS  PubMed  Google Scholar 

  51. Grossman MC, Cohen PR, Grossman ME. Acquired eyelash trichomegaly and alopecia areata in a human immunodeficiency virus-infected patient. Dermatology. 1996;193(1):52–3.

    Article  CAS  PubMed  Google Scholar 

  52. Moghadam-Kia S, Franks AG. Autoimmune disease and hair loss. Dermatol Clin. 2013;31(1):75–91.

    Article  CAS  PubMed  Google Scholar 

  53. Yun SJ, Lee JW, Yoon HJ, Lee SS, Kim SY, Lee JB, et al. Cross-sectional study of hair loss patterns in 122 Korean systemic lupus erythematosus patients: a frequent finding of non-scarring patch alopecia. J Dermatol. 2007;34(7):451–5.

    Article  PubMed  Google Scholar 

  54. Werth VP, White WL, Sanchez MR, Franks AG. Incidence of alopecia areata in lupus erythematosus. Arch Dermatol. 1992;128(3):368–71.

    Article  CAS  PubMed  Google Scholar 

  55. Yell JA, Mbuagbaw J, Burge SM. Cutaneous manifestations of systemic lupus erythematosus. Br J Dermatol. 1996;135(3):355–62.

    Article  CAS  PubMed  Google Scholar 

  56. CrispĂŒn JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, Stillman IE, et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol. 2008;181(12):8761–6.

    Article  PubMed Central  PubMed  Google Scholar 

  57. Hunt SJ, Caserio RJ, Abell E. Primary systemic amyloidosis causing diffuse alopecia by telogen arrest. Arch Dermatol. 1991;127(7):1067–8.

    Article  CAS  PubMed  Google Scholar 

  58. Lutz ME, Pittelkow MR. Progressive generalized alopecia due to systemic amyloidosis. J Am Acad Dermatol. 2002;46(3):434–6.

    Article  PubMed  Google Scholar 

  59. Barja J, Piñeyro F, Almagro M, SacristĂ¡n F, RodrĂ­guez-Lojo R, FernĂ¡ndez-Jorge B, et al. Systemic amyloidosis with an exceptional cutaneous presentation. Dermatol Online J. 2013;19(1):11.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Eastern Virginia Medical School, 721 Fairfax Avenue, Suite 200, Norfolk, VA, 23507, USA

    Kimberly Scott Salkey M.D.

Authors
  1. Kimberly Scott Salkey M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kimberly Scott Salkey M.D. .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Nelson Clinic, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA

    Julia R. Nunley

  2. Department of Medicine, Section of Nephrology, University of Illinois at Chicago / Advocate Christ Medical Center, Oak Lawn, Illinois, USA

    Edgar V. Lerma

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Salkey, K.S. (2015). Alopecias. In: Nunley, J., Lerma, E. (eds) Dermatological Manifestations of Kidney Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2395-3_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2395-3_15

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2394-6

  • Online ISBN: 978-1-4939-2395-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation